130 (Mycophenolate mofetil 250 mg)

Pill imprint 130 has been identified as Mycophenolate mofetil 250 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; systemic lupus erythematosus; organ transplant, rejection prophylaxis; myasthenia gravis; pulmonary fibrosis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 130 (Mycophenolate mofetil 250 mg)

Mycophenolate mofetil 250 mg 130
Mycophenolate mofetil
Imprint:
130
Strength:
250 mg
Color:
Blue & White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Zydus Pharmaceuticals
National Drug Code (NDC):
68382-0130
Inactive Ingredients:
croscarmellose sodium
FD&C Blue No. 1
FD&C Red No. 3
magnesium stearate
gelatin
sodium lauryl sulfate
titanium dioxide
povidone k90
pregelatinized corn starch
silicon dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0177 Amerisource Health Services

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web2)